ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Cancer Immunotherapy Market Impressive Growth Rate USD 101.6 Billion At 14.8% CAGR Worldwide Forecasts by 2023 – Digital Journal

Last News 24Cancer Immunotherapy Market Impressive Growth Rate USD 101.6 Billion At 14.8% CAGR Worldwide Forecasts by 2023Digital JournalThe Global Cancer Immunotherapy Market 2017-2023 Industry Research Report is an expert comprehensive analysis repor… Continue reading

2017-11-27 Michael Zand NEWS

Immunotherapy drug can treat rare pregnancy cancer: Study – Economic Times

Economic TimesImmunotherapy drug can treat rare pregnancy cancer: StudyEconomic TimesThree out of four patients with the cancerous forms of gestational trophoblastic disease (GTD) went into remission after receiving the immunotherapy drug pembrolizumab… Continue reading

2017-11-27 Michael Zand NEWS

Cancer Immunotherapy Market Size, Growth, Potential, Opportunity Analysis To 2021 – Medgadget (blog)

Last News 24Cancer Immunotherapy Market Size, Growth, Potential, Opportunity Analysis To 2021Medgadget (blog)Cancer Immunotherapy Market Analysis Research Report 2017 is a premium research explores Cancer Immunotherapy Market Size, Growth, Potential, … Continue reading

2017-11-27 Michael Zand NEWS

Synthetic biology: Multiplex genome engineering in eukaryotes – Nature.com

Nature.comSynthetic biology: Multiplex genome engineering in eukaryotesNature.comA goal of synthetic biology is the design and evolution of organisms with new and improved properties, but genomic diversity is difficult to generate efficiently in the la… Continue reading

2017-11-27 Michael Zand NEWS

Critics wary of stem cell clinics that promise big results but have little regulation – Houston Chronicle

Continue reading

2017-11-27 Michael Zand NEWS

Gene therapy to fix failing hearts works in pigs and will be tried in humans in 2018 – Next Big Future

Next Big FutureGene therapy to fix failing hearts works in pigs and will be tried in humans in 2018Next Big FutureThe gene therapy was safe and reduced heart failure by 25 percent in the left ventricle by 20 percent in the left atrium. Hajjar says most… Continue reading

2017-11-27 Michael Zand NEWS

Gene therapy to fix failing hearts works in pigs and will be tried in humans in 2018 – Next Big Future

Next Big FutureGene therapy to fix failing hearts works in pigs and will be tried in humans in 2018Next Big FutureThe gene therapy was safe and reduced heart failure by 25 percent in the left ventricle by 20 percent in the left atrium. Hajjar says most… Continue reading

2017-11-27 Michael Zand NEWS

Startup Advancells is promoting stem cell technology to cure different diseases – Economic Times


Houston Chronicle

Critics wary of stem cell clinics that promise big results but have little regulation
Houston Chronicle
In April, Barden got an injection of stem cells at a Pearland clinic, one of more than 100 for-profit businesses in Texas providing the increasingly popular but unproven and expensive therapy. A recent report found the state is one of the nation’s stem …
Outlook of Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Research Report during 2017 …MilTech
Global Stem Cell Therapy Market 2017 – Recent Study Including Growth Factors, Applications, Regional Analysis, Key …Newsient (blog)

all 9 news articles »

Continue reading

2017-11-27 Michael Zand NEWS
  • 1
  • …
  • 846
  • 847
  • 848
  • 849
  • 850
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Economic Times

Startup Advancells is promoting stem cell technology to cure different diseases
Economic Times
Jain, who had been part of the healthcare marketing industry for more than a decade, decided to enter the field of stem cell research because of the field’s untapped and unmatched potential. “Around 2009-10, people started approaching me with queries …